Back

Kiniksa Pharmaceuticals Quote, Financials, Valuation and Earnings

Your Chance To Invest In The Green Energy Revolution!

Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!

Buy

KNSA
Kiniksa Pharmaceuticals

Last Price:

14.16

Seasonality Move:

-5.39%

7 Day Trial

ALL ACCESS PASS

$ 7

New Year, New Trades, Try A.I. Today

Learn to forecast trends with up to 87.4% proven accuracy -> Register Here

Kiniksa Pharmaceuticals Price Quote

$14.16

-0.36 (-2.48%)

(Updated: February 2, 2023 at 7:10 PM ET)

Kiniksa Pharmaceuticals Key Stats

Buy

Kiniksa Pharmaceuticals (KNSA) is a Buy

Day range:

$14.32 - $14.67

52-week range:

$7.36 - $17.20

Dividend yield:

P/E ratio:

0.00

P/S ratio:

5.67

P/B ratio:

2.62%

Volume:

367.6K

Avg. volume:

318.1K

1-year change:

26.92%

Market cap:

$1B

Revenue:

$38.5M

EPS:

How Much Does Kiniksa Pharmaceuticals Make?

How Much Are Kiniksa Pharmaceuticals's Sales Annually?
KNSA Revenues are $38.5M
How Much Profit Does Kiniksa Pharmaceuticals's Make A Year?
KNSA net income is -$157.9M

Is Kiniksa Pharmaceuticals Growing As A Company?

What Is Kiniksa Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 7.2%
What Is Kiniksa Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Kiniksa Pharmaceuticals Stock Price Performance

Did Kiniksa Pharmaceuticals Stock Go Up Last Month?
Kiniksa Pharmaceuticals share price went down by -3.07% last month
Did KNSA's Share Price Rise Over The Last Year?
KNSA share price rose by 26.92% over the past 1 year

What Is Kiniksa Pharmaceuticals 52-Week High & Low?

What Is Kiniksa Pharmaceuticals’s 52-Week High Share Price?
Kiniksa Pharmaceuticals has traded as high as $17.20 over the past 52 weeks
What Is Kiniksa Pharmaceuticals’s 52-Week Low Share Price?
Kiniksa Pharmaceuticals has traded as low as $7.36 over the past 52 weeks

Kiniksa Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Kiniksa Pharmaceuticals?

How Much Debt Does Kiniksa Pharmaceuticals Have?
Total long term debt quarterly is $0
How Much Cash Does Kiniksa Pharmaceuticals Have?
Cash and short term investments quarterly total is $200.7M
What Is Kiniksa Pharmaceuticals’s Book Value Per Share?
Book value per share is 5.52

Is Kiniksa Pharmaceuticals Cash Flow Positive?

What Is KNSA Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.5M
What Is Kiniksa Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $2.5M
What Is Kiniksa Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$15.5M

Kiniksa Pharmaceuticals Return On Invested Capital

Is Management Doing A Good Job?
KNSA return on invested capital is 64.64%
What Is Kiniksa Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 51.39%
What Is KNSA Return On Equity?
ROE is a measure of profitability and is 64.64%

Kiniksa Pharmaceuticals Earnings Date & Stock Price

What Is Kiniksa Pharmaceuticals's Stock Price Today?
A single share of KNSA can be purchased today for 14.52
What Is Kiniksa Pharmaceuticals’s Stock Symbol?
Kiniksa Pharmaceuticals trades on the nasdaq under the ticker symbol: KNSA
When Is Kiniksa Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Kiniksa Pharmaceuticals is scheduled on February 22, 2023
When Is KNSA's next ex-dividend date?
Kiniksa Pharmaceuticals's next ex-dividend date is June 17, 2020
How To Buy Kiniksa Pharmaceuticals Stock?
You can buy Kiniksa Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Kiniksa Pharmaceuticals Competitors

Who Are Kiniksa Pharmaceuticals's Competitors?
Below is a list of companies who compete with Kiniksa Pharmaceuticals or are related in some way:
- Assertio Holdings Inc (ASRT)
- Johnson & Johnson (JNJ)
- NovaBay Pharmaceuticals Inc (NBY)
- Palatin Technologies Inc (PTN)
- Vir Biotechnology Inc (VIR)

Kiniksa Pharmaceuticals Dividend Yield